DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 76 filers reported holding DYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,289 | -20.4% | 2,376 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $26,730 | +13.2% | 2,376 | +15.9% | 0.00% | 0.0% |
| Q1 2023 | $23,616 | -0.6% | 2,050 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23,760 | -27.5% | 2,050 | -20.6% | 0.00% | -50.0% |
| Q3 2022 | $32,791 | +84.9% | 2,582 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $17,738 | -28.7% | 2,582 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $24,890 | -78.6% | 2,582 | -73.6% | 0.00% | -50.0% |
| Q4 2021 | $116,070 | +1.6% | 9,762 | +38.7% | 0.00% | 0.0% |
| Q3 2021 | $114,281 | -41.1% | 7,037 | -23.7% | 0.00% | -33.3% |
| Q2 2021 | $193,926 | +76.7% | 9,217 | +76.4% | 0.00% | +50.0% |
| Q4 2020 | $109,746 | – | 5,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |